ABVC Earnings
Latest RevenueN/A
Latest Net Income-810481
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | -$0.03 | 0 | -810481 | — | +76.9% |
| Q1 2026 | -$0.06 | 0 | -1689937 | — | +0.0% |
| Q4 2025 | — | — | — | — | — |
| Q3 2025 | -$0.05 | 796.0K | -1287523 | +104.5% | -66.7% |
| Q2 2025 | -$0.13 | 0 | -2332833 | -100.0% | -62.5% |
| Q1 2025 | -$0.06 | 0 | -944190 | -100.0% | +79.3% |
| Q4 2024 | -$0.06 | 2.0K | -796527 | -9.2% | +0.0% |
| Q3 2024 | -$0.03 | 389.3K | -487431 | +2,350.7% | +96.3% |
| Q2 2024 | -$0.08 | 117.1K | -1047412 | — | — |
| Q1 2024 | -$0.29 | 1.2K | -2927667 | — | — |
| Q4 2023 | -$0.06 | 2.2K | -700309 | — | — |
| Q3 2023 | -$0.82 | 15.9K | -3368080 | — | — |
ABVC BioPharma (ABVC) — Earnings